Showing results (151-160 of 170) with videos related to
Sort By:
Pageof 17
JCI Insight|December 22, 2017
Computational analysis of antibody dynamics identifies recent HIV-1 infectionKelly E Seaton, Nathan A Vandergrift, Aaron W Deal, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 25, 2024
Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine TrialNigel Garrett, One Dintwe, Cynthia L Monaco, et al.Science Translational Medicine|January 26, 2018
Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomesAida Sivro, Alexandra Schuetz, Daniel Sheward, et al.Plos One|January 31, 2020
Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South AfricansLue Ping Zhao, Andrew Fiore-Gartland, Lindsay N Carpp, et al.Cell Host & Microbe|October 24, 2021
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent mannerRoanne Keeton, Simone I Richardson, Thandeka Moyo-Gwete, et al.Cell Host & Microbe|February 5, 2025
Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth developmentMaria C Hesselman, Marius Zeeb, Peter Rusert, et al.Research Square|July 3, 2023
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence featuresCraig Magaret, Li Li, Allan deCamp, et al.Emerging Microbes & Infections|April 7, 2025
A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trialsZoe Moodie, Shuying Sue Li, Elena E Giorgi, et al.Lancet (London, England)|March 20, 2022
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation studyLinda-Gail Bekker, Nigel Garrett, Ameena Goga, et al.Nature Medicine|August 22, 2022
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisitionPeter B Gilbert, Yunda Huang, Allan C deCamp, et al.Pageof 17